ArticleScientific reports2026
Hsa-circ_0081481-miR 3960-FBXO24 regulatory axis in non-obstructive azoospermia identifies potential biomarkers of spermatogenic failure.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The etiology of non-obstructive azoospermia (NOA) remains largely idiopathic, emphasizing the urgent need for molecular biomarkers to predict sperm retrieval outcomes. Here, we integrate bioinformatic analyses of public transcriptomic data with experimental expression profiles to investigate a potential regulatory network involving hsa-circ_0081481, miR-3960 and FBXO24 in NOA. Seven GEO datasets were analyzed to identify differentially expressed genes, and FBXO24 was found to be a consistently downregulated gene in NOA. Upstream regulators and interacting non-coding RNAs were predicted, leading to the selection of miR-3960 (a microRNA targeting FBXO24) and hsa-circ_0081481 (a circular RNA predicted to sponge miR-3960). Subsequently, FBXO24, miR-3960 and hsa-circ_0081481 expression levels were measured in the plasma of 60 men with NOA (categorized by histopathology and sperm retrieval outcome) and 40 fertile controls. FBXO24 and hsa-circ_0081481 were significantly downregulated in NOA (especially in hypospermatogenesis and maturation arrest), whereas miR-3960 was significantly upregulated in these subgroups. Of note, hsa-circ_0081481 achieved excellent diagnostic performance (AUC 0.920) in distinguishing NOA cases with successful and failed sperm retrieval, respectively. miR-3960 also showed high accuracy (AUC 0.861) after its inverse expression pattern was taken into account, and FBXO24 showed moderate predictive value. Our findings suggest that the hsa-circ_0081481/miR-3960/FBXO24 axis is dysregulated in NOA and may serve as a novel trio of non-invasive biomarkers. This study provides new insights into the molecular mechanisms of spermatogenic failure in NOA and provides a basis for improved diagnosis and personalized fertility treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.